Form 8-K - Current report:
SEC Accession No. 0001558370-25-002177
Filing Date
2025-03-04
Accepted
2025-03-04 16:31:44
Documents
13
Period of Report
2025-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20250226x8k.htm   iXBRL 8-K 42108
  Complete submission text file 0001558370-25-002177.txt   160580

Data Files

Seq Description Document Type Size
2 EX-101.SCH tech-20250226.xsd EX-101.SCH 3394
3 EX-101.LAB tech-20250226_lab.xml EX-101.LAB 15263
4 EX-101.PRE tech-20250226_pre.xml EX-101.PRE 10902
15 EXTRACTED XBRL INSTANCE DOCUMENT tech-20250226x8k_htm.xml XML 4647
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 25705208
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)